TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
KROS

Keros Therapeutics Inc

Healthcare · Biotechnology

11.40$ +5.8% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Keros Therapeutics Inc (KROS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 338 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KROS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
27 11 269 255 307 370 616 338
26 8.9 268 251 286 347 589 315
23 7.0 266 230 279 331 560 287
23 7.0 266 230 279 331 560 287
0.9 0.2 18 0.8 1.1 4.5 6.4
0.8 1.5 3.1 -0.8 14
1.4 1.9 1.6 1.3 2.0
15 5.5 7.7 12 29 38 44 35
11 4.5 7.2 12 17 24 27 20
0.2 0.4 0.4 0.9 0.5 1.0 2.0 2.4
0.5 2.1 2.1 3.6 3.3 5.5 4.6 2.0
2.4 5.0
13 5.5 262 243 277 332 572 303
-7.3 -20 -65 -124 -228 -381 -569 -482
8.9 8.9 16 23 25 29 37 38

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?